2012
DOI: 10.1016/j.ajpath.2012.07.017
|View full text |Cite
|
Sign up to set email alerts
|

Combined Inhibition of c-Abl and PDGF Receptors for Prevention and Treatment of Murine Sclerodermatous Chronic Graft-versus-Host Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
7
2
1

Relationship

3
7

Authors

Journals

citations
Cited by 29 publications
(21 citation statements)
references
References 37 publications
0
21
0
Order By: Relevance
“…Mice were treated from d21 to d56 post transplantation. Mice undergoing syngeneic transplantation of bone marrow cells and splenocytes served as controls 29 30…”
Section: Methodsmentioning
confidence: 99%
“…Mice were treated from d21 to d56 post transplantation. Mice undergoing syngeneic transplantation of bone marrow cells and splenocytes served as controls 29 30…”
Section: Methodsmentioning
confidence: 99%
“…The B10.D2→Balb/c (H-2(d)) minor histocompatibility antigen-mismatched model was used as a model of SSc with systemic fibrosis 8 12 13. cGvHD was induced by allogeneic transplantation of 5×10 6 splenocytes and 1×10 6 bone marrow cells from B10.D2 mice into BALB/c (H-2d) mice as described.…”
Section: Methodsmentioning
confidence: 99%
“…Imatinib has shown promising results in clinical trials of steroid-refractory cGvHD patients (238, 239). An enhanced effect was observed by simultaneous targeting of both PDGFRα- and TGF-β signaling pathways using Imatinib and Nilotinib, the latter targeting c-Abl in the intracellular pathway induced by TGF-β (240). …”
Section: Chronic Gvhdmentioning
confidence: 99%